Annual accounts receivable:
$4.42B-$240.00M(-5.15%)Summary
- As of today (June 22, 2025), GILD annual accounts receivable is $4.42 billion, with the most recent change of -$240.00 million (-5.15%) on December 31, 2024.
- During the last 3 years, GILD annual accounts receivable has fallen by -$73.00 million (-1.62%).
- GILD annual accounts receivable is now -24.50% below its all-time high of $5.85 billion, reached on December 31, 2015.
Performance
GILD Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$4.39B-$32.00M(-0.72%)Summary
- As of today (June 22, 2025), GILD quarterly accounts receivable is $4.39 billion, with the most recent change of -$32.00 million (-0.72%) on March 1, 2025.
- Over the past year, GILD quarterly accounts receivable has dropped by -$281.00 million (-6.02%).
- GILD quarterly accounts receivable is now -28.80% below its all-time high of $6.16 billion, reached on March 31, 2016.
Performance
GILD Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
GILD Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.2% | -6.0% |
| 3 y3 years | -1.6% | +15.9% |
| 5 y5 years | +23.4% | +12.3% |
GILD Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -7.5% | at low | -8.4% | +15.9% |
| 5 y | 5-year | -9.7% | +23.4% | -10.3% | +37.4% |
| alltime | all time | -24.5% | +8954.8% | -28.8% | +8889.2% |
GILD Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $4.39B(-0.7%) |
| Dec 2024 | $4.42B(-5.2%) | $4.42B(-3.6%) |
| Sep 2024 | - | $4.59B(-1.6%) |
| Jun 2024 | - | $4.66B(-0.1%) |
| Mar 2024 | - | $4.67B(+0.2%) |
| Dec 2023 | $4.66B(-2.4%) | $4.66B(-2.7%) |
| Sep 2023 | - | $4.79B(+13.3%) |
| Jun 2023 | - | $4.23B(+1.6%) |
| Mar 2023 | - | $4.16B(-12.9%) |
| Dec 2022 | $4.78B(+6.3%) | $4.78B(+9.7%) |
| Sep 2022 | - | $4.35B(+5.7%) |
| Jun 2022 | - | $4.12B(+8.7%) |
| Mar 2022 | - | $3.79B(-15.7%) |
| Dec 2021 | $4.49B(-8.2%) | $4.49B(-1.6%) |
| Sep 2021 | - | $4.57B(+10.1%) |
| Jun 2021 | - | $4.15B(+5.7%) |
| Mar 2021 | - | $3.92B(-19.8%) |
| Dec 2020 | $4.89B(+36.6%) | $4.89B(+25.0%) |
| Sep 2020 | - | $3.91B(+22.5%) |
| Jun 2020 | - | $3.19B(-18.2%) |
| Mar 2020 | - | $3.91B(+9.1%) |
| Dec 2019 | $3.58B(+7.7%) | $3.58B(+8.1%) |
| Sep 2019 | - | $3.31B(-2.4%) |
| Jun 2019 | - | $3.40B(+3.4%) |
| Mar 2019 | - | $3.28B(-1.3%) |
| Dec 2018 | $3.33B(-13.6%) | $3.33B(-4.0%) |
| Sep 2018 | - | $3.46B(-2.1%) |
| Jun 2018 | - | $3.54B(-6.2%) |
| Mar 2018 | - | $3.77B(-2.0%) |
| Dec 2017 | $3.85B(-14.7%) | $3.85B(-6.6%) |
| Sep 2017 | - | $4.12B(-7.9%) |
| Jun 2017 | - | $4.48B(+11.0%) |
| Mar 2017 | - | $4.03B(-10.6%) |
| Dec 2016 | $4.51B(-22.9%) | $4.51B(-11.1%) |
| Sep 2016 | - | $5.08B(-11.8%) |
| Jun 2016 | - | $5.75B(-6.7%) |
| Mar 2016 | - | $6.16B(+5.3%) |
| Dec 2015 | $5.85B(+26.3%) | $5.85B(-4.1%) |
| Sep 2015 | - | $6.11B(+14.5%) |
| Jun 2015 | - | $5.33B(+10.3%) |
| Mar 2015 | - | $4.83B(+4.3%) |
| Dec 2014 | $4.63B(+112.4%) | $4.63B(+62.6%) |
| Sep 2014 | - | $2.85B(-17.1%) |
| Jun 2014 | - | $3.44B(+6.2%) |
| Mar 2014 | - | $3.24B(+48.3%) |
| Dec 2013 | $2.18B(+24.6%) | $2.18B(+10.7%) |
| Sep 2013 | - | $1.97B(+4.0%) |
| Jun 2013 | - | $1.90B(-2.5%) |
| Mar 2013 | - | $1.95B(+11.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $1.75B(-10.2%) | $1.75B(-0.8%) |
| Sep 2012 | - | $1.77B(+3.7%) |
| Jun 2012 | - | $1.70B(-21.3%) |
| Mar 2012 | - | $2.16B(+10.9%) |
| Dec 2011 | $1.95B(+20.3%) | $1.95B(+4.5%) |
| Sep 2011 | - | $1.87B(-3.7%) |
| Jun 2011 | - | $1.94B(+7.6%) |
| Mar 2011 | - | $1.80B(+11.1%) |
| Dec 2010 | $1.62B(+16.7%) | $1.62B(-2.9%) |
| Sep 2010 | - | $1.67B(+12.6%) |
| Jun 2010 | - | $1.48B(-0.6%) |
| Mar 2010 | - | $1.49B(+7.3%) |
| Dec 2009 | $1.39B(+35.8%) | $1.39B(+3.8%) |
| Sep 2009 | - | $1.34B(+7.7%) |
| Jun 2009 | - | $1.24B(+16.4%) |
| Mar 2009 | - | $1.07B(+4.4%) |
| Dec 2008 | $1.02B(+28.7%) | $1.02B(-2.3%) |
| Sep 2008 | - | $1.05B(+2.5%) |
| Jun 2008 | - | $1.02B(+4.2%) |
| Mar 2008 | - | $979.80M(+23.2%) |
| Dec 2007 | $795.13M(+30.5%) | $795.13M(-1.1%) |
| Sep 2007 | - | $803.63M(+9.4%) |
| Jun 2007 | - | $734.51M(+6.1%) |
| Mar 2007 | - | $692.07M(+13.6%) |
| Dec 2006 | $609.32M(+53.8%) | $609.32M(+4.1%) |
| Sep 2006 | - | $585.05M(+19.6%) |
| Jun 2006 | - | $489.32M(+12.8%) |
| Mar 2006 | - | $433.63M(+9.5%) |
| Dec 2005 | $396.13M(+6.7%) | $396.13M(-1.1%) |
| Sep 2005 | - | $400.62M(+7.7%) |
| Jun 2005 | - | $371.98M(-3.5%) |
| Mar 2005 | - | $385.44M(+3.8%) |
| Dec 2004 | $371.25M(+57.8%) | $371.25M(+22.0%) |
| Sep 2004 | - | $304.30M(+9.7%) |
| Jun 2004 | - | $277.31M(+7.7%) |
| Mar 2004 | - | $257.49M(+9.5%) |
| Dec 2003 | $235.22M(+88.1%) | $235.22M(+17.0%) |
| Sep 2003 | - | $201.06M(+0.4%) |
| Jun 2003 | - | $200.31M(+37.2%) |
| Mar 2003 | - | $145.98M(+16.8%) |
| Dec 2002 | $125.04M(+68.4%) | $125.04M(+9.6%) |
| Sep 2002 | - | $114.06M(+12.4%) |
| Jun 2002 | - | $101.46M(+31.9%) |
| Mar 2002 | - | $76.94M(+3.6%) |
| Dec 2001 | $74.23M(+52.1%) | $74.23M(+25.0%) |
| Sep 2001 | - | $59.40M(+9.3%) |
| Jun 2001 | - | $54.35M(+6.2%) |
| Mar 2001 | - | $51.19M(+4.9%) |
| Dec 2000 | $48.81M | $48.81M |
FAQ
- What is Gilead Sciences annual accounts receivable?
- What is the all time high annual accounts receivable for Gilead Sciences?
- What is Gilead Sciences annual accounts receivable year-on-year change?
- What is Gilead Sciences quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Gilead Sciences?
- What is Gilead Sciences quarterly accounts receivable year-on-year change?
What is Gilead Sciences annual accounts receivable?
The current annual accounts receivable of GILD is $4.42B
What is the all time high annual accounts receivable for Gilead Sciences?
Gilead Sciences all-time high annual accounts receivable is $5.85B
What is Gilead Sciences annual accounts receivable year-on-year change?
Over the past year, GILD annual accounts receivable has changed by -$240.00M (-5.15%)
What is Gilead Sciences quarterly accounts receivable?
The current quarterly accounts receivable of GILD is $4.39B
What is the all time high quarterly accounts receivable for Gilead Sciences?
Gilead Sciences all-time high quarterly accounts receivable is $6.16B
What is Gilead Sciences quarterly accounts receivable year-on-year change?
Over the past year, GILD quarterly accounts receivable has changed by -$281.00M (-6.02%)